What are the potential long-term ophthalmic risks of GLP-1 receptor agonists like semaglutide? (Medscape AI)

https://www.medscape.com/ai-search?query=What%20are%20the%20potential%20long-term%20ophthalmic%20risks%20of%20GLP-1%20receptor%20agonists%20like%20semaglutide%3f&ecd=mkm_ret_251230_mscpmrk_ophth_best-of-the-year_etid7996262&uac=148436CN&impID=7996262 GLP-1 receptor agonists, including semaglutide, have been linked to several ophthalmic concerns over prolonged use. Clinicians should be aware of the following potential risks: